Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dreyling, M, Ghielmini, M, Rule, S, Salles, G, Vitolo, U, Ladetto, M
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dreyling, M., Ghielmini, M., Rule, S., Salles, G., Ladetto, M., Tonino, S.H., Herfarth, K., Seymour, J.F., Jerkeman, M.
Published in Annals of oncology (01.03.2021)
Published in Annals of oncology (01.03.2021)
Get full text
Journal Article
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dreyling, M., Campo, E., Hermine, O., Jerkeman, M., Le Gouill, S., Rule, S., Shpilberg, O., Walewski, J., Ladetto, M.
Published in Annals of oncology (01.07.2017)
Published in Annals of oncology (01.07.2017)
Get full text
Journal Article
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dreyling, M, Geisler, C, Hermine, O, Kluin-Nelemans, H C, Le Gouill, S, Rule, S, Shpilberg, O, Walewski, J, Ladetto, M
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
Fraser, G, Cramer, P, Demirkan, F, Silva, R Santucci, Grosicki, S, Pristupa, A, Janssens, A, Mayer, J, Bartlett, N L, Dilhuydy, M-S, Pylypenko, H, Loscertales, J, Avigdor, A, Rule, S, Villa, D, Samoilova, O, Panagiotidis, P, Goy, A, Pavlovsky, M A, Karlsson, C, Hallek, M, Mahler, M, Salman, M, Sun, S, Phelps, C, Balasubramanian, S, Howes, A, Chanan-Khan, A
Published in Leukemia (01.04.2019)
Published in Leukemia (01.04.2019)
Get full text
Journal Article
Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
Rule, S, Jurczak, W, Jerkeman, M, Rusconi, C, Trneny, M, Offner, F, Caballero, D, Joao, C, Witzens-Harig, M, Hess, G, Bence-Bruckler, I, Cho, S-G, Thieblemont, C, Zhou, W, Henninger, T, Goldberg, J, Vermeulen, J, Dreyling, M
Published in Leukemia (01.08.2018)
Published in Leukemia (01.08.2018)
Get full text
Journal Article
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma
Robinson, S, Dreger, P, Caballero, D, Corradini, P, Geisler, C, Ghielmini, M, Le Gouill, S, Kimby, E, Rule, S, Vitolo, U, Dreyling, M, Hermine, O
Published in Leukemia (01.02.2015)
Published in Leukemia (01.02.2015)
Get full text
Journal Article
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial
McMillan, A.K., Phillips, E.H., Kirkwood, A.A., Barrans, S., Burton, C., Rule, S., Patmore, R., Pettengell, R., Ardeshna, K.M., Lawrie, A., Montoto, S., Paneesha, S., Clifton-Hadley, L., Linch, D.C.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Guidelines for the investigation and management of mantle cell lymphoma
McKay, P., Leach, M., Jackson, R., Cook, G., Rule, S.
Published in British journal of haematology (01.11.2012)
Published in British journal of haematology (01.11.2012)
Get full text
Journal Article
Measuring In Vitro ATPase Activity for Enzymatic Characterization
Rule, Chelsea S, Patrick, Marcella, Sandkvist, Maria
Published in Journal of visualized experiments (23.08.2016)
Published in Journal of visualized experiments (23.08.2016)
Get full text
Journal Article
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dreyling, M, Ghielmini, M, Rule, S, Salles, G, Vitolo, U, Ladetto, M
Published in Annals of oncology (01.12.2017)
Published in Annals of oncology (01.12.2017)
Get full text
Journal Article
Specific Labeling of Threonine Methyl Groups for NMR Studies of Protein–Nucleic Acid Complexes
Sinha, Kaustubh, Jen-Jacobson, Linda, Rule, Gordon S
Published in Biochemistry (Easton) (29.11.2011)
Published in Biochemistry (Easton) (29.11.2011)
Get full text
Journal Article
Long term follow‐up of untreated/relapsing MCL patients with the Ibrutinib, obinutuzumab, and venetoclax combination
Le Gouill, S., Morschhauser, F., Chiron, D., Bouabdallah, K., Cartron, G., Casasnovas, O., Rule, S., Bodet‐Milin, C., Herbaux, C., Gastinne, T., Callanan, M., Tessoulin, B.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Phase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies
Jurczak, W., Rule, S., Townsend, W., Tucker, D., Sarholz, B., Scheele, J., Gribben, J., Zinzani, P.L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Rainforest, woodland or swampland? Integrating time, space and culture to manage an endangered ecosystem complex in the Australian Wet Tropics
Lynch, A. J. J., Ferrier, Å., Ford, A. J., Haberle, S. G., Rule, S., Schneider, L., Zawadzki, A., Metcalfe, D. J.
Published in Landscape ecology (2020)
Published in Landscape ecology (2020)
Get full text
Journal Article
Characterization of Mechanisms of Resistance in Previously Treated Chronic Lymphocytic Leukemia (CLL) From a Head‐to‐Head Trial of Acalabrutinib Versus Ibrutinib
Woyach, J. A., Jones, D., Jurczak, W., Robak, T., Illés, A., Kater, A. P., Ghia, P., Byrd, J. C., Seymour, J. F., Long, S., Mohamed, N., Jesus, G., Lai, R., Bruin, G., Butturini, A., Rule, S., Munugalavadla, V.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors
Awada, A.H., Morschhauser, F., Machiels, J.-P., Salles, G., Rottey, S., Rule, S., Cunningham, D., Peyrade, F., Fruchart, C., Arkenau, H.-T., Genvresse, I., Koechert, K., Cisternas, G., Granvil, C., Pena, C., Liu, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article